InMed is a bio-pharmaceutical company that specializes in the research, development and commercialization of cannabinoid based pharmaceutical products. We take this class of compounds known as cannabinoids and we formulate these into disease specific products to treat diseases with high unmet medical needs.
Conference Presentation – InMed Presents at Life Sciences Forum December 11, 2025
In this update on InMed Pharmaceuticals, CEO Eric A. Adams talks about the company’s Alzheimer’s disease program. Mr. Adams talks about the role of inflammation
January 12, 2026
